CryoLife, Inc. (CRY) Tops Q2 EPS by 9c; Boosts Outlook
Tweet
Share
E-mailGet Alerts CRY Hot Sheet
Join SI Premium – FREE
CryoLife, Inc. (NYSE: CRY) reported Q2 EPS of $0.12, $0.09 better than the analyst estimate of $0.03. Revenue for the quarter came in at $33.2 million versus the consensus estimate of $32.79 million.
CryoLife, Inc. sees FY2012 EPS of $0.20-$0.23, versus the consensus of $0.17. CryoLife, Inc. sees FY2012 revenue of $129-$133 million, versus the consensus of $131.9 million.
For earnings history and earnings-related data on CryoLife, Inc. (CRY) click here.
CryoLife, Inc. sees FY2012 EPS of $0.20-$0.23, versus the consensus of $0.17. CryoLife, Inc. sees FY2012 revenue of $129-$133 million, versus the consensus of $131.9 million.
For earnings history and earnings-related data on CryoLife, Inc. (CRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
- Cytokinetics (CYTK) PT Raised to $110 at Barclays
- YETI Holdings, Inc. (YETI) Tops Q2 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
